Video

Alastair Noyce, MBBS, PhD

Dr. Noyce discusses PREDICT-PD, a longitudinal study in which healthy people over age 60 are stratified by risk of Parkinson’s disease.


 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

AAN updates botulinum toxin guidelines for most established uses
MDedge Neurology
Valbenazine Reduces Tardive Dyskinesia Severity
MDedge Neurology
AAN Updates Guidelines on Use of Botulinum Toxin for Four Disorders
MDedge Neurology
Extended-release amantadine may improve levodopa dyskinesia control
MDedge Neurology
Chromosomal Deletion May Increase the Risk of Parkinson’s Disease
MDedge Neurology
Rosacea Is a Risk Factor for Parkinson’s Disease
MDedge Neurology
Remotely Collected Data From Patients With Parkinson’s Disease Now Publicly Available
MDedge Neurology
FDA approves first drug to treat hallucinations in Parkinson’s psychosis
MDedge Neurology
Strong gender difference for stroke in diabetes patients with restless legs syndrome
MDedge Neurology
Strong gender difference for stroke in diabetes patients with restless legs syndrome
MDedge Neurology

Related Articles